Diabetes y enfermedades metabólicas
Universidad de Córdoba
Córdoba, EspañaPublications in collaboration with researchers from Universidad de Córdoba (7)
2024
-
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease
International Journal of Molecular Sciences, Vol. 25, Núm. 5
2022
-
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
Frontiers in Pharmacology, Vol. 13
-
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
International Journal of Molecular Sciences, Vol. 23, Núm. 7
2021
-
Bisphenol a modulates autophagy and exacerbates chronic kidney damage in mice
International Journal of Molecular Sciences, Vol. 22, Núm. 13
-
Protective role of nrf2 in renal disease
Antioxidants, Vol. 10, Núm. 1, pp. 1-31
2020
-
Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities
International Journal of Molecular Sciences, Vol. 21, Núm. 7
-
Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy
International Journal of Molecular Sciences, Vol. 21, Núm. 11